20090340: An Open Label Study Evaluating the Safety and Efficacy of Long-Term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects with Immune (Idiopathic) Thrombocytopenia Purpura (ITP)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/149/10/18

Funding

  • Amgen, Inc.
  • Amgen, Inc.